Small Cap Capital
Long/short equity, deep value, special situations, energy

Harvard Bioscience: Forgotten Stock Poised To Deliver Near-Term Results

Harvard Bioscience (NASDAQ:HBIO) is a global developer, manufacturer, and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used in life science research. Founded in 1901 at Harvard University Medical School under the name Harvard Apparatus, the company changed the name to Harvard Bioscience in 1996.

With annual revenue of $105 million in 2013, the company sells products in over 100 countries. Headquartered in Massachusetts, the company has manufacturing facilities in the US and Europe with sales offices in Canada, France, and China.

During the past few years, the company has focused on its regenerative business and implemented its internal R&D strategy on re-growing human organs in bio-reactors for life-saving transplantations. In November 4,...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details